PF-06282999 is an irreversible inactivator of myeloperoxidase, and currently in clinical trials for the potential treatment of cardiovascular diseases.
For research use only. We do not sell to patients.
| Name | PF-06282999 |
|---|---|
| Iupac Chemical Name | 2-(6-(5-chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide |
| Synonyms | PF 06282999;PF06282999; |
| Molecular Formula | C13H12ClN3O3S |
| Molecular Weight | 325.767 |
| Smile | O=C(N)CN(C(N1)=S)C(C2=CC(Cl)=CC=C2OC)=CC1=O |
| InChiKey | ICYNYWFGIDGBRD-UHFFFAOYSA-N |
| InChi | InChI=1S/C13H12ClN3O3S/c1-20-10-3-2-7(14)4-8(10)9-5-12(19)16-13(21)17(9)6-11(15)18/h2-5H,6H2,1H3,(H2,15,18)(H,16,19,21) |
| CAS Number | 1435467-37-0 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% by HPLC |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |